Blog

Catherine’s Story: My journey to my living donor kidney transplant and recovery.

Catherine’s Story: My journey to my living donor kidney transplant and recovery.   My diagnosis of Immunoglobulin A nephritis (IgAN) was made in February 1995.  I had normal function back then and whilst there was a steady decline in my renal function over the years, I wasn’t anywhere near to conversations around kidney transplantation. It

Catherine’s Story: My journey to my living donor kidney transplant and recovery. Read More »

Factors affecting efficacy (in terms of weight loss) of GLP-1 agonists

Factors affecting efficacy (in terms of weight loss) of GLP-1 agonists A recent study from the USA identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity (Gasoyan, 2024). Key points In the study, the

Factors affecting efficacy (in terms of weight loss) of GLP-1 agonists Read More »

Weight loss drug’s heart benefits extend to people with heart failure

Weight loss drug’s heart benefits extend to people with heart failure In a recent study (Lincoff, 2023) in The Lancet, found similar cardiovascular benefits for a subgroup of study participants who were also judged to have heart failure at the start of the trial. Why is this important? Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist,

Weight loss drug’s heart benefits extend to people with heart failure Read More »

Scroll to Top